Neutrophil receptors for interleukin-8 and related CXC chemokines - PubMed (original) (raw)
Affiliations
- PMID: 9347581
Review
Neutrophil receptors for interleukin-8 and related CXC chemokines
P M Murphy. Semin Hematol. 1997 Oct.
Abstract
Both the beneficial and harmful roles of neutrophils are critically dependent on the capacity of the cell to undergo directed migration from the blood to local tissue sites. Because the CXC chemokine interleukin-8 (IL-8) is a powerful mediator of this process, its receptor is a reasonable target for development of treatments for neutrophil-mediated inflammation. However, this strategy has been complicated by the discovery of two distinct IL-8 receptors, CXCR1 and CXCR2, that are coexpressed on human neutrophils. Both are 7-transmembrane domain-type proteins functionally coupled to G proteins. Although both receptors bind IL-8 with high affinity, they differ in selectivity for other CXC chemokines, as well as in their regulation and signal transduction, but whether they also differ biologically is not yet clear.
Similar articles
- Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2.
Feniger-Barish R, Ran M, Zaslaver A, Ben-Baruch A. Feniger-Barish R, et al. Cytokine. 1999 Dec;11(12):996-1009. doi: 10.1006/cyto.1999.0510. Cytokine. 1999. PMID: 10623425 - Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, Mongovin SM, Hagen TR, Steinberg KP, Goodman RB. Cummings CJ, et al. J Immunol. 1999 Feb 15;162(4):2341-6. J Immunol. 1999. PMID: 9973513 - Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J, Struyf S, Wuyts A, Weyler M, Loos T, Gijsbers K, Gouwy M, Proost P, Van Damme J. Catusse J, et al. Biochem Pharmacol. 2004 Nov 15;68(10):1947-55. doi: 10.1016/j.bcp.2004.07.003. Biochem Pharmacol. 2004. PMID: 15476666 - The interleukin-8 pathway in cancer.
Waugh DJ, Wilson C. Waugh DJ, et al. Clin Cancer Res. 2008 Nov 1;14(21):6735-41. doi: 10.1158/1078-0432.CCR-07-4843. Clin Cancer Res. 2008. PMID: 18980965 Review. - ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M. Bizzarri C, et al. Pharmacol Ther. 2006 Oct;112(1):139-49. doi: 10.1016/j.pharmthera.2006.04.002. Epub 2006 May 23. Pharmacol Ther. 2006. PMID: 16720046 Review.
Cited by
- Brief review on the roles of neutrophils in cancer development.
Long W, Chen J, Gao C, Lin Z, Xie X, Dai H. Long W, et al. J Leukoc Biol. 2021 Feb;109(2):407-413. doi: 10.1002/JLB.4MR0820-011R. Epub 2020 Sep 24. J Leukoc Biol. 2021. PMID: 32970873 Free PMC article. Review. - Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW, Raghuwanshi SK, Grant DJ, Jala VR, Rajarathnam K, Richardson RM. Nasser MW, et al. J Immunol. 2009 Sep 1;183(5):3425-32. doi: 10.4049/jimmunol.0900305. Epub 2009 Aug 10. J Immunol. 2009. PMID: 19667085 Free PMC article. - Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.
Peña-Romero AC, Orenes-Piñero E. Peña-Romero AC, et al. Cancers (Basel). 2022 Mar 25;14(7):1681. doi: 10.3390/cancers14071681. Cancers (Basel). 2022. PMID: 35406451 Free PMC article. Review. - Restriction of drug transport by the tumor environment.
Nandigama R, Upcin B, Aktas BH, Ergün S, Henke E. Nandigama R, et al. Histochem Cell Biol. 2018 Dec;150(6):631-648. doi: 10.1007/s00418-018-1744-z. Epub 2018 Oct 25. Histochem Cell Biol. 2018. PMID: 30361778 Review. - A key regulator of tumor-associated neutrophils: the CXCR2 chemokine receptor.
Kang W, Wang C, Wang M, Liu M, Hu W, Liang X, Yang J, Zhang Y. Kang W, et al. J Mol Histol. 2024 Dec;55(6):1051-1061. doi: 10.1007/s10735-024-10260-y. Epub 2024 Sep 13. J Mol Histol. 2024. PMID: 39269537 Review.